Plausible role of naringenin against cerebrally implanted C6 glioma cells in rats

Molecular and Cellular Biochemistry

Volumn 375, Issue 1-2, 2013, Pages 171-178

  Sabarinathan, Devan ^a   Vanisree, Arambakkam Janardhanam ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Akt; C6 glioma; COX 2; Naringenin; PGE2; PI3K

Indexed keywords

5' NUCLEOTIDASE; CREATINE KINASE; CYCLOOXYGENASE 2; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE TRANSFERASE; HEXOKINASE; MESSENGER RNA; NARINGENIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; GLIOMA; GLIOMA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN NEOPLASMS; CYCLOOXYGENASE 2; FLAVANONES; GENE EXPRESSION; GLIOMA; MALE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; RATTUS;

EID: 84873057041     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1539-9     Document Type: Article

References (33)

1. Kesari S, Ramakrishna N, Sauvageot C, Stiles CD, Wen PY (2006) Targeted molecular therapy of malignant gliomas. Curr Oncol Rep 8:58-70
2. Pamela N (2004) Cyclooxygenase in the treatment of glioma: its complex role in signal transduction. Cancer Control 11:152-164
3. Akhavan D, Cloughesy TF, Mischel PS (2010) mTOR signaling in glioblastoma: lessons learned from bench to bedside. Neurooncology 12:882-889. doi: 10.1093/neuonc/noq05
4. Inoue H, Kosaka T, Miyata A (1995) Structure and expression of the human prostaglandin endoperoxide synthase 2 gene. Adv Prostaglandin Thromboxane Leukot Res 23:109-111
5. Jiang BH, Liu LZ (2008) PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 1784:150-158
6. Joy AM, Beaudry CE, Tran NL, Ponce FA, Holz DR, Demuth T, Berens ME (2003) Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 116:4409-4417
7. Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G, Stokoe D (1998) Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol 8:1195-1198
8. St-Germain ME, Gagnon V, Mathieu I, Parent S, Asselin E (2004) AKT regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. Int J Oncol 24:1311-1324
9. Chen D, Chen MS, Cui QC, Yang H, Dou QP (2007) Structure-proteasome- inhibitory activity relationships of dietary flavonoids in human cancer cells. Front Biosci 12:1935-1945
10. Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M (1999) HL-60 differentiating activity and flavonoid content of the readily extractable fraction prepared from citrus juices. J Agric Food Chem 47:128-135
11. De Stefani E, Boffetta P, Oreggia F, Brennan P, Ronco A, Deneo-Pellegrini H, Mendilaharsu M (2000) Plant foods and risk of laryngeal cancer: a case-control study in Uruguay. Int J Cancer 87:129-132
12. Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C (2003) Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 85:180-192
13. Sabarinathan D, Mahalakshmi P, Vanisree AJ (2010) Naringenin promote apoptosis in cerebrally implanted C6 glioma cells. Mol Cell Biochem 345:215-222
14. Sabarinathan D, Mahalakshmi P, Vanisree AJ (2010) Naringenin: a flavanone inhibits the proliferation of cerebrally implanted C6 glioma cells in rats. Chemico-Biol Interact 189:26-36. doi: 10.1016/j.cbi.2010.09.028
15. Nobuhisa N, Hiroshi S, Masaru A, Kimiyoshi H (1993) Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol 86:117-125
16. Fiddo RJ, Tatham AS, Shewry PR (1995) Western blotting analysis and methods. Mol Biol 49:423-437
17. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917
18. Sabarinathan D, Vanisree AJ (2010) Naringenin: a flavanone alters the tumorigenic features of C6 glioma cells. Biomed Pharmacother doi: 10.1016/j.biopha.2010.06.010
19. Chalhoub N, Zhu G, Zhu X, Baker SJ (2009) Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains. Genes Dev 23:1619-1628
20. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2:489-501
21. Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606-619
22. Wang Q, Wang X, Hernandez A, Kim S, Evers BM (2001) Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation. Gastroenterology 120:1381-1392
23. Knobbe CB, Merlo A, Reifenberger G (2002) PTEN signaling in gliomas. Neurooncology 4:196-211
24. Burgering BM, Coffer PJ (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599-602
25. Fischer PM, Lane DP (2000) Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics. Curr Med Chem 7:1213-1245
26. Badie B, Schartner JM, Hagar AR, Prabakaran S, Peebles TR, Bartley B, Lapsiwala S, Resnick DK, Vorpahl J (2003) Microglia cyclooxygenase-2 activity in experimental gliomas: possible role in cerebral edema formation. Clin Cancer Res 9:872-877
27. Lupulescu A (1996) Prostaglandins, their inhibitors and cancer. Prostaglandins Leukot Essent Fatty Acids 54:83-94
28. Hernandez M, Bayon Y, Sanchez CM (1999) Signaling mechanisms involved in the activation of arachidonic acid metabolism in human astrocytoma cells by tumor necrosis factor-alpha: phosphorylation of cytosolic phospholipase A2 and transactivation of cyclooxygenase-2. J Neurochem 73:1641-1649
29. Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, Chen CS (2000) The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 275:11397-11403
30. Sweeney CJ (2003) Why cyclooxygenase-2 inhibition plus chemotherapy? Am J Clin Oncol 26:S122-S125
31. Fan XM, Jiang XH, Gu Q, Ching YP, He H, Xia HHX, Mi Lin MC, Chan AOO, Yuen MF, Kung HF, Wong BCY (2006) Inhibition of Akt/PKB by a COX-2 inhibitor induces apoptosis in gastric cancer cells. Digestion 73:75-83
32. Gustafson-Svärd C, Lilja I, Hallböök O, Sjödahl R (1996) Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. Gut 38:79-84
33. Gong JP, Wu CX, Liu CA, Li SW, Shi YJ, Li XH, Peng Y (2002) Liver sinusoidal endothelial cell injury by neutrophils in rats with acute obstructive cholangitis. World J Gastroenterol 8(2):342-345